178 related articles for article (PubMed ID: 28969475)
1. Peripheral and orofacial pain sensation is unaffected by the loss of p39.
Prochazkova M; Hall B; Hu M; Okine T; Reukauf J; Binukumar BK; Amin ND; Roque E; Pant HC; Kulkarni A
Mol Pain; 2017; 13():1744806917737205. PubMed ID: 28969475
[TBL] [Abstract][Full Text] [Related]
2. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
3. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y
J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679
[TBL] [Abstract][Full Text] [Related]
4. Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia.
Prochazkova M; Terse A; Amin ND; Hall B; Utreras E; Pant HC; Kulkarni AB
Mol Pain; 2013 Dec; 9():66. PubMed ID: 24359609
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.
Saito T; Yano M; Kawai Y; Asada A; Wada M; Doi H; Hisanaga SI
J Biol Chem; 2013 Nov; 288(45):32433-32439. PubMed ID: 24085300
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
[TBL] [Abstract][Full Text] [Related]
7. The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.
Luo F; Zhang J; Burke K; Miller RH; Yang Y
J Neurosci; 2016 Mar; 36(10):3024-37. PubMed ID: 26961956
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase 5 activity regulates pain signaling.
Pareek TK; Keller J; Kesavapany S; Pant HC; Iadarola MJ; Brady RO; Kulkarni AB
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):791-6. PubMed ID: 16407116
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
Asada A; Saito T; Hisanaga S
J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
[TBL] [Abstract][Full Text] [Related]
10. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
[TBL] [Abstract][Full Text] [Related]
11. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
[TBL] [Abstract][Full Text] [Related]
12. Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes.
Asada A; Yamamoto N; Gohda M; Saito T; Hayashi N; Hisanaga S
J Neurochem; 2008 Aug; 106(3):1325-36. PubMed ID: 18507738
[TBL] [Abstract][Full Text] [Related]
13. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
14. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S
Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974
[TBL] [Abstract][Full Text] [Related]
15. Cdk5: a new player in pain signaling.
Pareek TK; Kulkarni AB
Cell Cycle; 2006 Mar; 5(6):585-8. PubMed ID: 16552189
[TBL] [Abstract][Full Text] [Related]
16. Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.
Minegishi S; Asada A; Miyauchi S; Fuchigami T; Saito T; Hisanaga S
Biochemistry; 2010 Jul; 49(26):5482-93. PubMed ID: 20518484
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C
Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038
[TBL] [Abstract][Full Text] [Related]
18. p39-associated Cdk5 activity regulates dendritic morphogenesis.
Ouyang L; Chen Y; Wang Y; Chen Y; Fu AKY; Fu WY; Ip NY
Sci Rep; 2020 Oct; 10(1):18746. PubMed ID: 33127972
[TBL] [Abstract][Full Text] [Related]
19. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
Ko J; Humbert S; Bronson RT; Takahashi S; Kulkarni AB; Li E; Tsai LH
J Neurosci; 2001 Sep; 21(17):6758-71. PubMed ID: 11517264
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-Dependent Kinase 5 Regulates Dendritic Spine Formation and Maintenance of Cortical Neuron in the Mouse Brain.
Mita N; He X; Sasamoto K; Mishiba T; Ohshima T
Cereb Cortex; 2016 Mar; 26(3):967-976. PubMed ID: 25404468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
